BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7231991)

  • 1. [Development of Schwartz-Bartter syndrome following administration of chlorpropamide and 1-deamino-8-D-arginine vasopressin].
    Valkusz Z; Laczi F; László F
    Orv Hetil; 1981 Jan; 122(2):97-8. PubMed ID: 7231991
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of the Schwartz-Bartter syndrome after the administration of chlorpropamide and 1-deamino-8-D-arginine vasopressin.
    Valkusz Z; Laczi F; László FA
    Endokrinologie; 1982 Jul; 79(3):345-8. PubMed ID: 7128548
    [No Abstract]   [Full Text] [Related]  

  • 3. [Schwartz-Bartter syndrome following long-term DDAVP therapy in a patient with diabetes insipidus].
    Radó J; Pató E
    Orv Hetil; 1983 May; 124(22):1323-6. PubMed ID: 6877810
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of diabetes insipidus with synthetic vasopressin derivatives (effect of 1-deamino-8-D-arginine vasopressin and 1-deamino-valine-8-D-arginine vasopressin)].
    Czakó L; László F; Manning M
    Orv Hetil; 1980 Mar; 121(13):773-8. PubMed ID: 7383655
    [No Abstract]   [Full Text] [Related]  

  • 5. 1-deamino-/4-valine-8-D-arginine/-vasopressin (dVDAVP), a new synthetic vasopressin analog for treating diabetes insipidus.
    László FA; Czakó L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):39-43. PubMed ID: 7056603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Simultaneous occurrence of diabetes insipidus and diabetes mellitus (treatment of water-electrolyte imbalance with a vasopressin analog)].
    Vadász J; Czakó L
    Orv Hetil; 1980 Mar; 121(13):779-80. PubMed ID: 6992036
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental water intoxication induced by dDAVP in rat, and its prevention with the vasopressin antagonist d(CH2)5Tyr(Et)VAVP.
    László FA; Baláspiri L
    Acta Med Hung; 1986; 43(3):333-9. PubMed ID: 3588172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of water deprivation and water loading during treatment with 1-deamino-8-D-arginine vasopressin in central diabetes insipidus in childhood.
    Becker DJ; Foley TP
    Acta Endocrinol (Copenh); 1981 Jul; 97(3):358-60. PubMed ID: 7257701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
    Laczi F; Mezei G; Julesz J; Lázló FA
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pseudoresistance to DDAVP in diabetes insipidus].
    Radó J; Pató E; Czigner J; Fáber K
    Orv Hetil; 1985 Aug; 126(33):2043-6. PubMed ID: 4034192
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term treatment of diabetes insipidus with a synthetic analog of vasopressin during pregnancy.
    Sack J; Friedman E; Katznelson D; Frenkel Y
    Isr J Med Sci; 1980 May; 16(5):406-7. PubMed ID: 7399872
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergic reaction to DDAVP in diabetes insipidus: successful treatment with its graded doses.
    Yokota M; Matsukura S; Kaji H; Taminato T; Fujita T
    Endocrinol Jpn; 1982 Aug; 29(4):475-7. PubMed ID: 6217968
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes insipidus and other disorders of water balance.
    Oberfield SE
    Pediatr Ann; 1980 Oct; 9(10):384-9. PubMed ID: 7003519
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diabetes insipidus--with special reference to DDAVP therapy].
    Shimizu K
    Nihon Rinsho; 1979; 37(4):849-55. PubMed ID: 449070
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of elevation of urinary albumin excretion among patients with chronic syndromes of inappropriate antidiuresis.
    Vandergheynst F; Decaux G
    Nephrol Dial Transplant; 2008 Jul; 23(7):2399-401. PubMed ID: 18400823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of diabetes insipidus with DDAVP.
    Lampert RP; Blackett PR; Rennert OM
    J Pediatr; 1978 Nov; 93(5):896-7. PubMed ID: 712511
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experiences with the intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP)--effect of one time parenteral and intranasal applications].
    Tuschy U; Meinhold J; Szeszat S
    Z Gesamte Inn Med; 1983 Aug; 38(16):450-2. PubMed ID: 6636913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Desamino 8-D arginine-vasopressin in the diagnosis and treatment of central diabetes insipidus in a patient after cadaveric renal transplantation.
    Zeller WP; Heidkamp K; Hurley RM
    Transplant Proc; 1985 Aug; 17(4):2007-8. PubMed ID: 3895644
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pregnancy-induced diabetes insipidus].
    Bangsbøll S
    Ugeskr Laeger; 1993 Oct; 155(43):3491-3. PubMed ID: 8256344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.